$SOLV is trading 7.9% below its 200-day moving average.

Over the past 5 years, it's been this extreme just 0.7% of trading days.

Bargain hunting zone… or catch the knife?

How are you playing this?

#StockMarket $SOLV

Solventum profit jumps as it targets up to $6.60 a share in 2026 Q4 organic sales rose 3.5% to $2.0B while adjusted EPS reached $1.57. Solventum now forecasts 2026 organic growth of 2–3% and free cash flow near $200M.

#SOLV Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance

www.stocktitan.net/news/SOLV/solventum-repo...

Solventum Announces $1 Billion Share Repurchase Program Solventum (NYSE: SOLV) announced a Board-approved $1 billion share repurchase authorization on Nov 20, 2025.The company expects to begin repurchases in 2026 and had approximately 173.4 million shares outstanding as of Oct 31, 2025. Repurchases may occur in the open market, via Rule 10b5-1 or 10b-18 plans, privately negotiated transactions, or other means.The program has no time limit, does not obligate Solventum to buy shares, and may be suspended or discontinued; repurchases will depend on market conditions, liquidity, cash flow and applicable securities laws. Management cited strong cash generation and a concurrent acquisition of Acera Medical as context for the authorization.

#SOLV Solventum Announces $1 Billion Share Repurchase Program

www.stocktitan.net/news/SOLV/solventum-anno...

Solventum Announces Agreement to Acquire Acera Surgical Solventum (NYSE: SOLV) agreed to acquire Acera Surgical for $725 million cash plus up to $125 million in contingent cash payments tied to future milestones. The deal broadens Solventum's MedSurg portfolio into synthetic tissue matrices, part of a ~$900 million U.S. acute-care segment, and leverages Acera's Restrata® electrospun products and commercial footprint. Acera is expected to generate approximately $90 million in sales in 2025. Solventum plans to fund the transaction with cash on hand, use no new debt, expects closing in H1 2026, and projects the deal to be slightly dilutive to adjusted EPS in 2026 and accretive beginning in 2027.

#SOLV Solventum Announces Agreement to Acquire Acera Surgical

www.stocktitan.net/news/SOLV/solventum-anno...

WATCH, BUY or SELL + CHART 15/11/2025
SOLV/USDT WAL/USDT WLFI/USDT ZK/USDT
#SOLV #WAL #WLFI #ZK

WATCH, BUY or SELL + CHART 14/11/2025
SOLV/USDT WAL/USDT WLFI/USDT
#SOLV #WAL #WLFI

📈 Top Spot Gainers
🥇 RWACI/USDT 0.7350 (+8.41%) 🚀
🥈 TSLAx/USDT 445.9102 (+3.18%) ⬆️
🥉 SOLV/USDT 0.01643 (+2.21%) ⬆️
#Crypto #Spot #Gainers #MarketUpdate #RWACI #TSLAx #SOLV

WATCH, BUY or SELL + CHART 13/11/2025
SOLV/USDT WAL/USDT WLFI/USDT
#SOLV #WAL #WLFI

WATCH, BUY or SELL + CHART 12/11/2025
SOLV/USDT WAL/USDT WLFI/USDT
#SOLV #WAL #WLFI

WATCH, BUY or SELL + CHART 11/11/2025
SOLV/USDT HAMSTR/USDT WAL/USDT WLFI/USDT
#SOLV #HAMSTR #WAL #WLFI

WATCH, BUY or SELL + CHART 10/11/2025
SOLV/USDT HAMSTR/USDT WAL/USDT
#SOLV #HAMSTR #WAL

WATCH, BUY or SELL + CHART 09/11/2025
SOLV/USDT HAMSTR/USDT KDA/USDT WAL/USDT
#SOLV #HAMSTR #KDA #WAL

WATCH, BUY or SELL + CHART 08/11/2025
SOLV/USDT HAMSTR/USDT ROSE/USDT KDA/USDT
#SOLV #HAMSTR #ROSE #KDA

WATCH, BUY or SELL + CHART 07/11/2025
SOLV/USDT HAMSTR/USDT RESOLV/USDT
#SOLV #HAMSTR #RESOLV

#SOLV Solventum Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/SOLV/solventum-repo...

WATCH, BUY or SELL + CHART 06/11/2025
SOLV/USDT HAMSTR/USDT DGB/USDT RESOLV/USDT
#SOLV #HAMSTR #DGB #RESOLV

WATCH, BUY or SELL + CHART 05/11/2025
BTC/USDT MINA/USDT SOLV/USDT HAMSTR/USDT DGB/USDT
#BTC #MINA #SOLV #HAMSTR #DGB

WATCH, BUY or SELL + CHART 04/11/2025
BTC/USDT SCR/USDT MINA/USDT SOLV/USDT
#BTC #SCR #MINA #SOLV

🚀 Top Spot Gainers

🌟 ASTER/USDT — $1.1963 +23.82% 🔺

🔹 ARC/USDT — $0.0195 +12.64% 🔺

🧩 SOLV/SUDT — $0.02178 +10.81% 🔺

#Spot #Gainers #ASTER #ARC #SOLV #CryptoMarkets

Jiuzi Holdings Unveils $1 Billion Bitcoin Treasury with SOLV Partnership for Institutional Innovation Jiuzi Holdings, Inc. announces a significant partnership with SOLV, launching a $1 billion Bitcoin treasury aimed at global institutional investment and decentralized finance innovation.

Jiuzi Holdings Unveils $1 Billion Bitcoin Treasury with SOLV Partnership for Institutional Innovation #USA #N/A #Bitcoin_Treasury #Jiuzi_Holdings #SOLV

Jiuzi Holdings Launches $1 Billion Bitcoin Treasury with SOLV to Drive Institutional Finance Jiuzi Holdings introduces a groundbreaking $1 billion Bitcoin treasury in collaboration with SOLV, revolutionizing institutional finance.

Jiuzi Holdings Launches $1 Billion Bitcoin Treasury with SOLV to Drive Institutional Finance #USA #Hangzhou #Bitcoin_Treasury #Institutional_Finance #SOLV

Blaqsbi | Post: ‘’STAND UNITED‘’ In a world fractured by division and In a world fractured by division and suffering, STAND UNITED is a brand that symbolizes our shared humanity. It offers a simple, powerful way to show

Update: In a world fractured by division and suffering, "STAND UNITED" is a brand that symbolizes our shared humanity. It offers a simple, powerful way to show solidarity, champion... https://blaqsbi.com/ #Solv # talk

UK police use SOLV to power public appeals and awareness campaigns — from missing persons to fighting county lines and VAWG.
Reaching tens of thousands of people across communities.

#PublicSafety #UKPolice #VAWG #CountyLines #TechForGood #SOLV

Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers Solventum (NYSE: SOLV) has announced the pricing terms for its upsized note tender offers totaling $2.0 billion in aggregate purchase price. The company is offering to purchase multiple series of outstanding notes across two pools: Pool 1 with a maximum amount of $1.5 billion and Pool 2 with a maximum amount of $500 million.For Pool 1, Solventum expects to accept approximately $650 million of the 5.450% Senior Notes due 2027 (69.35% proration) and $797.3 million of the 5.400% Senior Notes due 2029 (61.24% proration). In Pool 2, about $457.6 million of the 6.000% Senior Notes due 2064 and $21.9 million of the 5.900% Senior Notes due 2054 will be accepted. Settlement is expected on September 10, 2025.

#SOLV Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers

www.stocktitan.net/news/SOLV/solventum-anno...

Solventum Increases Maximum Amounts in Recent Note Tender Offers for Better Financial Flexibility Solventum announces revised early tender results for its note tender offers, raising maximum purchase limits significantly to enhance liquidity and manage debt effectively.

Solventum Increases Maximum Amounts in Recent Note Tender Offers for Better Financial Flexibility #USA #Tender_Offers #St._Paul #Solventum #SOLV

Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. ST. PAUL, Minn., Sept. 2, 2025/ PRNewswire/-- Solventum today announced it has completed the sale of its Purification& Filtration business to Thermo Fisher Scientific Inc. for $4.0 billion in cash before customary adjustments. Organic sales growth in the range +2.0% to +3.0%; no change Increased adjusted EPS range to $5.88 to $6.03 from prior range of $5.80 to $5.95...

#SOLV #TMO Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.

www.stocktitan.net/news/SOLV/solventum-comp...

Solventum Announces $1.75 Billion Note Tender Offers Solventum (NYSE:SOLV) has launched tender offers to purchase up to $1.75 billion of its outstanding notes. The offers are divided into two pools: Pool 1 with a maximum purchase amount of $1.25 billion covering four series of notes, and Pool 2 with a maximum of $500 million covering two series of notes.Holders who tender their notes by the Early Tender Date of September 5, 2025, will receive the Total Consideration, which includes an Early Tender Payment of $30 per $1,000 principal amount. The tender offers will expire on September 22, 2025. The Early Settlement Date is expected around September 10, 2025, with the Final Settlement Date around September 25, 2025.

#SOLV Solventum Announces $1.75 Billion Note Tender Offers

www.stocktitan.net/news/SOLV/solventum-anno...

3M to sell $648M stake in Solventum through 8.8M share secondary offering Former 3M healthcare unit Solventum announces 8.8M share secondary offering priced by selling shareholder 3M Company. Goldman Sachs and BofA Securities lead the deal. See details.

#SOLV Solventum Announces Pricing of Secondary Offering of Common Stock

www.stocktitan.net/news/SOLV/solventum-anno...

3M Company to Sell 8.8 Million Shares in Newly Spun-off Solventum Secondary Offering Former 3M healthcare unit Solventum announces secondary offering with Goldman Sachs and BofA Securities as underwriters. 3M to sell entire stake. Learn more about the deal.

#SOLV Solventum Announces Launch of Secondary Offering of Common Stock

www.stocktitan.net/news/SOLV/solventum-anno...

Solv Introduces Institutional-Grade Yield Vault for Bitcoin Holders - Crypto Economy Solv Protocol, a staking platform focused on Bitcoin, has introduced BTC+, a high-quality yield vault aimed at generating returns from inactive Bitcoin assets.

🏦 Solv unveils new Bitcoin yield vault for institutions 📈

Solv Protocol introduces a product aimed at BTC holders seeking smarter capital strategies through institutional-grade design.

#Solv #Bitcoin #BTC #finance #crypto